Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.272
-0.028 (-9.30%)
Mar 6, 2026, 4:00 PM EST
Integrated BioPharma Revenue
Integrated BioPharma had revenue of $11.28M in the quarter ending December 31, 2025, a decrease of -10.58%. This brings the company's revenue in the last twelve months to $52.09M, down -0.06% year-over-year. In the fiscal year ending June 30, 2025, Integrated BioPharma had annual revenue of $54.35M with 8.02% growth.
Revenue (ttm)
52.09M
Revenue Growth
-0.06%
P/S Ratio
0.18
Revenue / Employee
340.46K
Employees
153
Market Cap
9.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 54.35M | 4.04M | 8.02% |
| Jun 30, 2024 | 50.32M | -355.00K | -0.70% |
| Jun 30, 2023 | 50.67M | -5.57M | -9.91% |
| Jun 30, 2022 | 56.25M | -7.31M | -11.51% |
| Jun 30, 2021 | 63.56M | 10.79M | 20.45% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hi-Great Group Holding Company | 48.03K |
| BAB, Inc. | 3.44M |
| GPO Plus | 5.22M |
| Strake | 223.07K |
| Glucose Health | 1.11M |
| China Foods Holdings | 422.40K |
| DAVIDsTEA | 43.33M |
Integrated BioPharma News
- 25 days ago - Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 - Accesswire
- 3 months ago - Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions - GlobeNewsWire
- 4 months ago - Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 - Accesswire
- 5 months ago - Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 - Accesswire
- 10 months ago - Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 - Accesswire
- 1 year ago - Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 - Accesswire